Skip to main content
Clinical Trials/NCT04759391
NCT04759391
Unknown
Not Applicable

Effects of Digital Pelvic Floor Muscle Training and Lifestyle Recommendations in Patients With Multiple Sclerosis Having Lower Urinary Tract Symptoms

Ataturk Training and Research Hospital1 site in 1 country30 target enrollmentFebruary 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lower Urinary Tract Symptoms
Sponsor
Ataturk Training and Research Hospital
Enrollment
30
Locations
1
Primary Endpoint
Incontinence symtoms
Last Updated
5 years ago

Overview

Brief Summary

The aim of this study was to investigate the effects of digital pelvic floor muscle training and lifestyle recommendations in patients with Multiple Sclerosis having lower urinary tract symptoms.

Detailed Description

Multiple sclerosis (MS) is an autoimmune, neurodegenerative disease of the central nervous system. Lower urinary tract symptoms (LUTS) are very common in MS. Pelvic floor muscle training (PFMT) is one of the first-line choices for the conservative treatment of LUTS. According to our knowledge, no study has investigated the effects of digital pelvic floor muscle training and lifestyle recommendations in MS having LUTS, yet.

Registry
clinicaltrials.gov
Start Date
February 2021
End Date
July 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ataturk Training and Research Hospital
Responsible Party
Principal Investigator
Principal Investigator

Seyda TOPRAK CELENAY

associate professor

Ataturk Training and Research Hospital

Eligibility Criteria

Inclusion Criteria

  • Having a diagnosis of MS and having at least two of the lower urinary symptoms
  • Not having an attack in the last 1 month,
  • No change in medical treatment in the last 3 months
  • "Expanded disability status scale-EDSS" score is less than 6.5
  • Not having any cognitive problems that would hinder cooperation and understanding
  • Those who use digital devices such as computers, laptops, smartphones and tablets
  • Volunteering to participate in the study

Exclusion Criteria

  • Pregnancy status
  • Active urinary tract infection
  • Another neurological disease that can cause incontinence
  • A history of malignancy
  • Prostate surgery
  • Those with missing evaluation parameters
  • Those who do not regularly participate in treatment programs

Outcomes

Primary Outcomes

Incontinence symtoms

Time Frame: change from baseline at 8 weeks

Urinary incontinence symptoms will be evaluated with The International Consultation of Incontinence Questionnaire - Short Form

Overactive bladder symptoms

Time Frame: change from baseline at 8 weeks

Overactive bladder symptoms will be evaluated with Overactive Bladder Questionnaire-Version8

Secondary Outcomes

  • patient satisfaction(after treatment (8th week))
  • Quality of life level(change from baseline at 8 weeks)
  • bladder functions(change from baseline at 8 weeks)
  • subjective perception of improvement(after treatment (8th week))

Study Sites (1)

Loading locations...

Similar Trials